|
Good response
Hi Lynn,
How wonderful that your counts have increases again! The problem with MDS is that it isn't one disease but many diseases with some symptoms that we all share. This means that we will respond different to treatment.
You have responded to one of the "latest" drugs - the histone deacetylase inhibitors (HDAC inhibitors) and there are several other drugs of that type in clinical trials for MDS.
It is really very important to try to find which patient that will respond to a special drug and we hope they will find something in your and others responders bone marrow cells that will tell us that patients with this feature will respond to Epival.
Kind regards
Birgitta-A
|